The Cullin4A (cul4A)-dependent ligase (CDL4A) E3 has been implicated in a variety of biological processes, including cell cycle progression and DNA damage response. Remarkably, CDL4A exerts its function through both proteolytic and non-proteolytic events. Here, we show that the p53 family member p73 is able to interact with the CDL4A complex through its direct binding to the receptor subunit DNA-binding protein 1 (DDB1). As a result, the CDL4A complex is able to monoubiquitylate p73. Modification of p73 by CDL4A-mediated ubiquitylation does not affect p73 protein stability, but negatively regulates p73-dependent transcriptional activity. Indeed, genetic or RNA interference-mediated depletion of DDB1 induces the expression of several p73 target genes in a p53-independent manner. In addition, by exploiting a bioinformatic approach, we found that elevated expression of Cul4A in human breast carcinomas is associated with repression of p73 target genes. In conclusion, our findings add a novel insight into the regulation of p73 by the CDL4A complex, through the inhibition of its transcriptional function.
INTRODUCTION
The modular cullin-dependent E3 ubiquitin ligases (E3 CDLs) represent a large and diverse superfamily of E3s. The cullin subunit acts as a scaffold to bridge the target substrate to activated ubiquitin and forms a base platform for the RING finger domain protein Roc1, recruiting the E2 ubiquitin-conjugating enzyme (E2).
In mammals, the CDL4 are assembled by two closely related cullins, Cul4A and Cul4B (83% identical), which form two separate independent E3s. The substrate-recruiting mechanism of the CDL4 implies the damaged DNA-binding protein 1 (DDB1), which either directly 1, 2 or in association with a subset of WD40 repeat adaptor proteins, [3] [4] [5] [6] binds to the target molecule. DDB1 is unique among cullin adaptors in that it contains a double-propeller pocket through which it can recruit substrates to the E3 complex. 7 The CDL4A E3s have been largely involved in the proteolysis of nucleotide excision repair components, replication inhibitors and cell cycle regulators 3, [8] [9] [10] [11] [12] (reviewed in Hannah and Zhou 13 ). Notably, Cul4A mRNA levels increase at the G1/S transition, when Cdt1 and cell cycle inhibitors such as p21 are degraded in a CDL4A-dependent manner. 10 As a result, deletion of DDB1 in mice causes early embryonic lethality.
14 Conditional ablation of DDB1 in the nervous system and epidermis leads to genomic instability and apoptosis of proliferating progenitor cells in mutant embryos, and causes profound cell growth defects in DDB1 À / À mouse embryonic fibroblasts (MEFs). 9, 14 On the other hand, Cul4A-deficient mice are viable and do not show overt developmental defect, likely owing to functional compensation by Cul4B. 11 Notably, skin-specific Cul4A ablation dramatically increases resistance to ultravioletinduced skin carcinogenesis, concomitantly with augmented levels of DDB2, XPC and p21. 11, 15 Therefore, high levels of Cul4A expression seen in certain cancer patients can accelerate neoplastic transformation by inhibiting both DNA repair and DNA damage checkpoint pathways.
p73 is a structural and functional homolog of the tumor suppressing transcription factor p53, which transactivates p53-responsive genes and mediates cell cycle arrest and apoptosis in response to DNA damage. 16, 17 Similarly to p53, p73 has been implicated in the regulation of tumorigenesis and chemotherapy response. 18, 19 Hence, much effort has been devoted to identify mechanisms underlying p73 protein stability and functional regulation in normal and cancer cells. p73 is mainly regulated at the post-translational level. The major E3-controlling p73 protein turnover is the HECT-type E3 Itch. 20 In addition to Itch-mediated regulation of p73 protein stability, we have recently shown that p73 is recruited to the SCF E3 complex through its interaction with the F-box protein FBXO45. 21 Similarly to Itch, the SCF-FBXO45 complex targets p73 for protein degradation.
Here we show that, through direct interaction with DDB1, p73 is recruited to the CDL4A complex, where its monoubiquitylation is promoted. As a result, p73 transcriptional activation and biological functions are repressed. Our findings add novel insights into the regulation of cell cycle and apoptotic cell death by the CDL4A complex, through the repression of p73-dependent transcription.
RESULTS AND DISCUSSION
p73 is recruited to the CDL4A complex through DDB1 interaction Cul4A was previously shown to interact with p53, bridging p53 to Mdm2 and thus promoting its proteasomal degradation. 22 Similarly, we found that p73 interacts with Cul4A in both wildtype and p53 null cell lines (Supplementary Figure S1) , whereas Cul4B and several unrelated cullin proteins do not bind to p73 (not shown), indicating the specificity of the cul4A-p73 association.
As cullins can be found associated with the substrates of the CDLs, 21 even though they do not directly mediate their recruitment, we sought to establish through which interactions p73 is targeted to the CDL4A complex. As DDB1 can directly recruit a protein substrate, 1,2 we first examined the association between p73 and DDB1 proteins, and found that they interact when ectopically expressed in either wild-type or p53 null cell lines (Figures 1a and b; Supplementary Figure S1 ). Relevantly, endogenous DDB1 was readily detected in p73 immunocomplexes in p53-null HCT116 (HCT116 p53 À / À ) cells (Figure 1c ). In addition, we found that the N-terminal region of p73, encompassing residues 1-320 and including the DNA-binding domain, was necessary and sufficient for the binding of p73 to endogenous DDB1 (Supplementary Figure S1) . To verify whether DDB1 mediates direct recruitment of p73 to the CDL4A complex, we tested the ability of recombinant purified p73 to interact with glutathione S-transferase-tagged DDB1 in in vitro pull-down assays. As shown in Figure 1d , p73 directly and strongly binds to DDB1.
The DDB1-Cul4A-Roc1 ubiquitin ligase catalyzes p73 ubiquitylation but does not affect its protein stability As co-expression of TAp73 and DDB1 induces dose-dependent appearance of a slower migrating form of p73 (Figure 2a) , we reasoned that recruitment of p73 to the CDL4A complex might promote its protein ubiquitylation. We thus tested the ability of a purified recombinant glutathione S-transferase-DDB1-Cul4A-Roc1 complex to promote p73 ubiquitylation in in vitro ubiquitylation assays. In the presence of the purified CDL4A complex, slowly migrating forms of p73 were detected (Figure 2b) . Importantly, the ubiquitin conjugates of p73 were unaffected by the presence of methylated ubiquitin (Figure 2b , lane 2), whose modification prevents the elongation of polyubiquitin chains. In addition, a similar pattern of p73 modification was obtained by employing methylated ubiquitin instead of wild-type ubiquitin (Figure 2b , lane 3). These findings reveal that p73 is modified by the CDL4A complex through multi-ubiquitylation and confirm that p73 recruitment by the CDL4A does not require further substraterecognition subunits.
While Lys48-linked polyubiquitin chains label proteins for 26S proteasome-mediated degradation, mono-and multi-ubiquitylation generally exert non-proteolytic roles. Consistently, we found that the expression of DDB1 neither led to p73 destabilization nor affected its decay rate (Figures 2a and c) . Consistently, downregulation of DDB1 did not affect p73 protein levels, whereas it caused accumulation of known CDL4A substrates, such as c-Jun and p21 (Figures 2d and e).
As monoubiquitylation modulates protein localization, 23 we tested whether p73 modification by the CDL4a complex would À / À cells were transiently transfected using the calcium phosphate method, with expression vectors encoding Flag-DDB1 and HA-p73a (a) or no-tagged DDB1 and Flag-TAp73a (b), respectively. After 24 h, cells were lysed and the DDB1/p73a immunocomplexes were analyzed by immunoprecipitation (IP) using a monoclonal anti-Flag (Clone M2, Sigma, St Louis, MO, USA) antibody, followed by immunoblot (IB) with anti-HA (clone H11, Covance, Richmond, CA, USA) for p73 detection (a), or with a goat anti-DDB1 antibody (Novus Biological, Littleton, CO, USA) (b). (c) Cell lysates were prepared from HCT116-p53 À / À and endogenous p73 immunoprecipitated with rabbit polyclonal anti-p73 antibody 30 or mouse immunoglobulin G, and resolved by SDS-polyacrylamide gel electrophoresis followed by IB with anti-DDB1 and anti-p73 (Clone 5B429, IMGENEX, San Diego, CA, USA) antibodies. The p73 input is revealed following a prolonged exposure time (bottom panel, see the arrow). The Tet-On-inducible Saos-2 cells expressing TAp73a were used as positive control (lane 1). For IP assays, cells lysates were precleared with protein G-Sepharose beads (GE Healthcare, Chalfont St Giles, Buckinghamshire, UK) for 3 h, and then immunoprecipitated with 1-2 mg per sample of the appropriate antibodies, previously adsorbed on protein G-Sepharose beads (Roche Molecular Biochemicals, Mannheim, Germany). (d) Bacterially purified glutathione S-transferase (GST)-DDB1 was mixed with His-tagged TAp73a recombinant protein bound to nickelcharged agarose resin beads (Qiagen, Duesseldorf, Germany) in binding buffer containing 50 mM Tris-HCl, pH 7.4, 200 mM NaCl, for 2 h at 4 1C. The protein-protein interaction complexes were eluted by adding elution buffer (50 mM Tris-HCl, pH 7.4, 200 mM NaCl, 200 mM imidazole), and resolved by SDS-polyacrylamide gel electrophoresis followed by IB with anti-DDB1 antibody. alter p73 nuclear distribution pattern, 17 and, consequently, impairs its transcriptional function. Nevertheless, p73 localization remains confined to the nuclear compartment upon expression of both Cul4A and DDB1 (Supplementary Figure S2) . All together, these data indicate that p73 associates with the CDL4A complex by specifically interacting with DDB1, and is monoubiquitylated at multiple sites, although this modification does not affect either its protein stability or protein localization.
The CDL4A complex inhibits p73 transcriptional activity As the activity of certain transcriptional factors is regulated by ubiquitylation, [23] [24] [25] we tested the effect of the CDL4A complex on p73 transcriptional function. Interestingly, by using the gadd45-luciferase reporter system, we found that overexpression of DDB1 in p53-null cells resulted in a dose-dependent decrease of p73 transactivation activity (Figure 3a, Supplementary Figure S3) . On the contrary, DDB1 had only a slight effect on p53 transcriptional function (Supplementary Figure S3) . Notably, silencing of DDB1 in HCT116 p53
À / À cells increased the ability of p73 to transactivate the Gadd45 promoter (Figure 3b ). On the contrary, the activation of the Gadd45 promoter by p73 was not significantly altered by ectopic expression of either wild-type or dominant-negative Cul4A mutants in HCT116 p53
À / À cells (data not shown), indicating that, being the recruiting receptor for p73, DDB1 may likely be the limiting factor for the repressive transcriptional function of the CDL4A complex.
To confirm the repressive role exerted by CDL4A on p73 transcriptional activity, we measured the levels of some p73 target genes in HCT116 p53
À / À cells upon siRNA-mediated silencing of DDB1. We found that Gadd45, p21 and PUMA transcripts (Figure 3c , left panel) and protein levels (Figure 3c , right panel) increased, following DDB1 downregulation. As described for other cell types, 14 upon DDB1 depletion, HCT116 p53 À / À cells displayed decreased proportion of S phase and increased percentage of arrested cells at the G2/M phase, as compared with control cells (Figure 3d, left panel) . In addition, DDB1 silencing augmented the levels of cell death as revealed by an increase of the sub-G0/G1 population (Figure 3d , right and bottom panels), which correlated with the induction of PUMAa (Figure 3c Figure S3) . In both model systems, we indeed observed upregulation of p73 target genes as a result of DDB1 depletion. Importantly, as HCT116 p53
À / À and BT-20 (harboring mutated p53) cells do not express detectable levels of endogenous p63 (26 and data not shown), we could exclude indirect effects of DDB1 ablation on the transcriptional function of other p53 family members. Similarly, genetic ablation of DDB1 in DDB1 F/F MEFs was not accompanied by p53 accumulation (Supplementary Figure S3) . In addition, we did not detect phosphorylation of histone H2AX in DDB1-depleted cells Bacterially expressed and purified recombinant His-TAp73a was assayed in a 15-ml reaction mixture (2.5 mM Tris-HCl, 0.7 mM DTT, 4 mM ATP, 10 mM MgCl 2 , 1 mM ubiquitin aldehyde) containing 10 ng E1 (Enzo Life Sciences Inc., New York, NY, USA), 0.5 mg E2 UbcH5 (Enzo Life Sciences Inc.), 1 mg of the CDL4A complex (Cul4A-DDB1-Roc1) and 2.5 mg ubiquitin (Enzo Life Sciences Inc.), in the absence or in the presence of 2.5 mg methylated ubiquitin (Met-Ub) (Enzo Life Sciences Inc.). The CDL4A complex was purified from Sf9 insect cells, which were co-infected with human Cul4A, DDB1 and Roc1-expressing baculoviruses. After incubation at 30 1C for 90 min, p73 polyubiquitylated species were resolved by SDS-polyacrylamide gel electrophoresis and detected using anti-p73 antibody (Abcam, Cambridge, MA, USA). (c) HEK-293 T cells were transfected with a construct expressing HA-TAp73a in the presence of Flag-DDB1 (right panels) or control plasmid (left panels). Twenty-four hours after transfection, 80 mg/ml cycloheximide (CHX) was added to the culture medium to inhibit protein synthesis. At different time points after CHX addition, cells were harvested and cellular extracts were analyzed for p73 levels by using anti-HA antibody.
(d) HCT116-p53
À / À cells were transiently transfected with a control scramble small interfering RNA (siRNA) oligo or with siRNA duplexes targeting DDB1 at final concentration of 100 nM, using Oligofectamin (Invitrogen, Carlsbad, CA, USA). The siRNA oligos were synthesized by Qiagen with the following target sequences: control scramble siRNA: 5 0 -AACAGTCGCGTTTGCGACTGG-3 0 ; DDB1 siRNA #1: 5 0 -ATGCAGAATCGACTCAATAAA-3 0 ; and DDB1 siRNA #2: 5 0 -ACCTATCA-CAATGGTGACAAA-3 0 . We performed two cycles of siRNA transfection, and 24 h after the second transfection, cells were harvested and cellular extracts analyzed by IB using anti p73 (Abcam), anti-c-jun (BD Biosciences, San josè, CA, USA) and anti-b-actin antibodies. (e) Cell lysates were prepared from BT-20 cells infected with control scramble lentiviral particles or a lentivirus containing short hairpin RNA (shRNA) against DDB1 (Sigma), at MOI 2, for 12 h at 37 1C in Dulbecco's Modified Eagle Medium containing 8 mg/ml polybrene. Twenty-four hours after infection, cells were selected in 2 mg/ml puromycin for 5 days. Cellular extracts were analyzed by IB using anti-DDB1 and anti-p73 antibodies (Abcam). The same membranes were reprobed with anti-b-actin and p21 (Clone F5, Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies as a loading and internal controls, respectively. Figure S4) , thus indicating that loss of DDB1 in our model system did not activate a DNA damage response.
To evaluate whether DDB1 may alter p73 binding affinity for DNA, the association of the p73 protein to the native Mdm2 promoter was assayed by chromatin immunoprecipitation (ChIP) assay under condition of DDB1 downregulation. However, we did not observe any enrichment in the p73 fraction bound to the Mdm2 promoter as compared with control cells (Supplementary Figure S5) . We next performed double ChIP experiments to measure the extent of DDB1 co-precipitated with TAp73 bound to its targeted promoters. Interestingly, we found that the binding of p73 to the promoters of p21 and Mdm2 genes was associated with a significant enrichment of DDB1 to these DNA regions (Supplementary Figure S5) . Collectively, these results suggest that p73 may provide the targeting specificity to the DDB1-Cul4a complex by recruiting the latter to its target genes for transcriptional repression.
Cul4A reduces the efficiency of correlation of p73 with its targets in clinical samples Cul4A is amplified or overexpressed in human breast carcinoma cell lines and primary tumors. 27 In order to verify whether the Cul4A/DDB1/p73 axis exists also in primary human tumors, we first analyzed Cul4A and DDB1 expression levels in a cluster of 980 human breast cancers in public cancer microarray data sets (Supplementary Table S1 ). We found that Cul4A, but not DDB1 expression, is variable across samples (Figure 4a ). On the basis of these data, we decided to search for a possible correlation between Cul4A levels and expression of p73 target genes. By splitting the samples in tumors expressing high or low levels of Cul4A, we found that expression of p73 correlates to its target at low expression of Cul4A, whereas does not correlate at high expression of Cul4A (Table 1 ). These data indicate that the overexpression of Cul4A represses p73 transcriptional activity in a clinical setting.
Along the same line, we found a negative correlation between the expression of Cul4A and p73 targets in a panel of human breast carcinoma cell lines, with high levels of Cul4A (Figure 4b , upper panel) being associated with repression of Gadd45 and p21 (Figure 4b, bottom panels) . Altogether, these findings suggest that Cul4A amplification/overexpression in human breast carcinomas may induce deregulation of p73 transcriptional activity.
Our data highlight a non-proteolityc role for the CDL4A complex in negatively regulating p73 function. Indeed, we found de-repression of p73-mediated transcription, following the depletion of DDB1 in both human and mouse cells. p53 is either absent/mutated (HCT116 p53 À / À and BT-20 cells) or does not accumulate in the absence of DDB1 (DDB1 F/F MEFs) in our models. Hence, the p53/p73 responsive genes are likely induced in a p73-dependent manner, following DDB1 depletion, even though the p21 protein may also accumulate as a result of decreased activity of the CDL4A E3. [9] [10] [11] Under our condition, we also observed that DDB1 depletion is associated with cell cycle arrest and cell death. However, as the CDL4A E3 targets cell cycle regulators for ubiquitin-mediated proteolysis, and its ablation induces the accumulation of DNA damage, we cannot rule out the possibility that the growth arrest and apoptotic phenotype observed upon DDB1 downregulation could be partly ascribed to its function in the DNA damage checkpoint response. Nevertheless, the absence of histone H2AX phosphorylation in cells silenced for DDB1 expression indicates that, at least under these conditions, the cellular effects of DDB1 ablation are not the result of accumulated unrepaired DNA damage because of altered nucleotide excision repair pathway. Hence, our results indicate that the proapoptotic effects of DDB1 ablation may, at least partially, arise from increased p73 transcriptional activation.
Mechanistically, ubiquitylation of p73 by the CDL4A E3 could alter its transactivating properties (Figure 4c, left panel) . The CDL4A complex was previously shown to interact with p53. 22 However, the recruitment mechanisms of p53, through L2DTL/CDT2 and PCNA 28 and p73, via DDB1, differ significantly. Furthermore, the biological outcome of p53 association with the CDL4A is protein degradation owing to the ability of the complex to increase the interaction of p53 with its E3 Mdm2. 22 Although Mdm2 does not target p73 for protein ubiquitylation, it acts as a binding partner for p73 and as an inhibitor of its transcriptional activity. 29 Interestingly, the expression of DDB1 and Cul4A potentiates the association of p73 and Mdm2 (not shown), thus suggesting the existence of a putative ternary complex in which the recruitment of p73 by DDB1 may place p73 in close proximity to Cul4A-bound Mdm2. According to this model, repression of p73 by the CDL4A complex may be mediated by Mdm2 (Figure 4c, right panel) . For each pair of genes, the P-value indicates a probability to split samples from the metadata set randomly into two groups and get the difference in absolute values of correlation (between groups) higher than the one for original split (split on the basis of the Cul4A expression value).
